Health Care/Hospital
Veeva Pulse Data Shows New Science Calls for More Connected Engagement
Synchronizing sales and marketing improves outcomes, yet 65% of field
engagements are not
SINGAPORE, Dec. 5, 2024 /PRNewswire/ -- Veeva Systems
2024-12-05 09:00
1651
Former CSL CEO Paul Perreault appointed strategic adviser to Microbio
Establishing sepsis diagnostic InfectID™ as the new standard of care BRISBANE, Australia, Dec. 5, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has today announced the appointment ofPaul Perreault as a st...
2024-12-05 06:30
1755
Soprano Design & BT Win Smarter Workflows Award for NHS Solution
SOPRANO & BT TAKE HOME GOLD FOR CONVERSATIONAL AI SOLUTION REDUCING DID NOT ATTENDS & STREAMLINING CLINICAL PATHWAYS IN THE UK SYDNEY, Dec. 5, 2024 /PRNewswire/ -- Soprano Design, in partnership with BT, is thrilled to announce that its Patient Concierge solution has won the Smarter Workflows Aw...
2024-12-05 05:00
1593
LBB Specialties and Clariant Partner to Distribute High-Quality Pharmaceutical Grade PEGs for Ophthalmic Applications
NORWALK, Conn., Dec. 5, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, announced a strategic partnership with Clariant, a global leader in specialty chemical manufacturing. Through this collaboration, LBB Specialties will ...
2024-12-05 04:02
1342
CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms
HONG KONG, Dec. 4, 2024 /PRNewswire/ -- The Chinese University of Hong Kong's Faculty of Medicine (CU Medicine) has, for the first time, discovered novel microbial signatures associated with inflammation of the gastrointestinal (GI) tract and transformed such signatures into clinically applicable...
2024-12-04 22:26
1776
Rhein Laser Announces FDA 510(k) Clearance of UroFiber 60Q
The Most Powerful Thulium SuperPulsed Fiber Laser for Urology is Here WUHAN, China, Dec. 4, 2024 /PRNewswire/ -- Rhein Laser Technologies Co., Ltd. is proud to announce that its UroFiber® 60Q SuperPulsed Thulium Fiber Laser System received FDA 510(k) clearance (K242293) onNovember 19, 2024, marki...
2024-12-04 22:00
1401
China NMPA approves Simcere's Sanbexin® sublingual tablets for the treatment of Acute Ischemic Stroke
NANJING, China, Dec. 4, 2024 /PRNewswire/ -- On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets), an innovative drug for stroke, has been approved for marketing by the National Medical Products Admini...
2024-12-04 18:10
1534
Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy for PD-(L)1 Resistant NSCLC Showcased in Oral Presentation at 2024 Asian Conference on Lung Cancer
HONG KONG, Dec. 4, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the results from a prospective, open-label, single-arm, multi-center phase Ib/II clinical study (AK104-IIT-018) of cadonilimab (PD-1/CTLA-4 bispecific antibody) in patients with advanced or metastat...
2024-12-04 13:09
1411
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter
AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to use an all-in-one high-density mapping and dual energy ablation catheter for the treatment of persistent atria...
2024-12-04 10:07
1506
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
* Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission. * In the high dose cohort, 6 out of 7 (85.7%) patients achieved overall clinical remission and ...
2024-12-04 09:10
2098
Exciting Offers Await at the 2024 Hong Kong Brands and Products Expo: Herbalgy Presents Exclusive Deals & Debuting "Yick Kee Balanced Tea Limited" Health Tea Bags!
Exclusive Discounts Up to 38% and Limited Edition Gifts HONG KONG, Dec. 4, 2024 /PRNewswire/ -- As December approaches, the highly anticipated Hong Kong Brands and Products Expo is just around the corner. Herbalgy Pharmaceutical Limited, a proud participant in this annual shopping event for many...
2024-12-04 09:00
1796
Duality Biologics and GSK Enter Exclusive Option Agreement for a Novel Antibody-drug Conjugate (DB-1324)
PRINCETON, N.J., SHANGHAI and SUZHOU, China, Dec. 3, 2024 /PRNewswire/ -- Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjugate (ADC) therapeutics, today announced that it has entered into an exclusi...
2024-12-04 08:30
1169
Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer
SAN FRANCISCO, U.S. and SUZHOU, China, Dec. 4, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...
2024-12-04 08:00
2140
Half of Australians live with chronic health conditions, over a third forced to leave their jobs as a result
Patient advocates call for more support for Australian workers living with a chronic condition/s following the release of a new insights report SYDNEY, Dec. 4, 2024 /PRNewswire/ -- A new report released today has found that of the one in two Australians living with a chronic health condition/s, ...
2024-12-04 05:57
1351
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery
* VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following cataract surgery * Statistically and clinically meaningful reductions in inflammation and ...
2024-12-04 00:00
1679
Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia
After years of commitment to animal health in the Asian market providing high-quality biotechnological solutions, this significant milestone further strengthens the company's long-term expansion strategy in the region. This is also reinforced by the recent launch of the FMD vaccine, Bioaftogen, i...
2024-12-03 23:34
2276
ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
First Implants of Innovative Device Completed in the United States and Australia MINNEAPOLIS, Dec. 3, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage innovator in neuromodulation technology, today announced the initiation of its U.S. Food and Drug Administration (FDA)-approved Investigation D...
2024-12-03 23:07
1233
TraceLink Announces Grant Recipients Driving Impact Across the Globe
BOSTON, Dec. 3, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has announced the recipients of its 2024 corporate grant program. The grants have been awarded to five nonprofit organizations acrossthe United States...
2024-12-03 23:00
1273
Momcozy Launches 'Love in Action' Charity Contest to Support Mothers This Holiday Season
NEW YORK, Dec. 3, 2024 /PRNewswire/ -- The global one-stop mother and baby
brand Momcozy
2024-12-03 23:00
950
Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow
Researchers from Children's Hospital of Philadelphia (CHOP) seek to expand treatment access for patients MOUNTAIN VIEW, Calif., Dec. 3, 2024 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA medicines for untreatable, age-related conditions, ...
2024-12-03 22:00
1308
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 290 media titles]
2025-01-14 21:00
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26
Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
20749
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
6566
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
6070
Boqii Announces ADS Ratio Change
2025-01-11 05:30
5127
Sino Land Included in Dow Jones Sustainability World Index
2025-01-10 22:01
5111
